Unique Pharm`s Generic Clomipramine Hydrochloride Receives Approval in US
Unique Pharm`s Generic Carbamazepine Receives Approval in US
Unique's Generic Glipizide Receives Approval In US
QuVa Pharma, Inc., a newly formed national platform for sterile compounding pharmacy services, has acquired the assets of Unique Pharmaceuticals, Ltd., including its state-of-the-art 503B manufacturing facility. With the acquisition, QuVa Pharma is addressing supply shortage issues that routinely and adversely impact the industry, and securing significant, immediately-available capacity in a second location. QuVa Pharma received a majority equity commitment from Bain Capital Private Equity, a leading global investment firm, as part of its formation in August. Financial terms of the private transaction were not disclosed.